Group One Trading
EIGR

Group One Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Group One Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$354 – 8149
2022
Q4 		$354 Buy
+10
New +$1.2K ﹤0.01% 6984
2022
Q2 		– Sell
-73
Closed -$18K – 8735
2022
Q1 		$18K Sell
73
-44
-38% -$6.95K ﹤0.01% 6839
2021
Q4 		$18K Sell
117
-10
-8% -$1.93K ﹤0.01% 7046
2021
Q3 		$25K Sell
127
-420
-77% -$99.9K ﹤0.01% 7052
2021
Q2 		$140K Buy
547
+444
+431% +$111K ﹤0.01% 5611
2021
Q1 		$27K Buy
+103
New +$32.5K ﹤0.01% 6622
2020
Q4 		– Sell
-7
Closed -$2K – 7141
2020
Q3 		$2K Buy
+7
New +$2.18K ﹤0.01% 5854
2016
Q2 		– Sell
-93
Closed -$47K – 5020
2016
Q1 		$47K Buy
93
+87
+1,450% +$43.3K ﹤0.01% 3288
2015
Q4 		$4K Sell
6
-155
-96% -$87.7K ﹤0.01% 4434
2015
Q3 		$76K Sell
161
-88
-35% -$46.7K ﹤0.01% 3242
2015
Q2 		$141K Buy
249
+97
+64% +$268K ﹤0.01% 2820
2015
Q1 		$1.29M Buy
+152
New +$1.33M 0.02% 887

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's EIGR Position: Q1 2023 in Review

Group One Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 409 shares — an estimated $19K sold.

Group One Trading first reported a position in EIGR in Q2 2015 and held it in 13 quarters. The position peaked at $72K in Q1 2022. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

  • Group One Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 409 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $19K.
  • Group One Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
  • Group One Trading's Eiger BioPharmaceuticals, Inc. position peaked at $72K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.